Studying gene expression in a cancer patient's cells can help clinical biologists understand the cancer's origin and predict the success of different treatments. But cells are complex and contain many ...
As pain is such a heterogeneous indication, significant opportunities remain for a variety of different and more effective non-opioid treatment options to be developed.
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
Artificial intelligence in its most successful form -- things like ChatGPT or DeepMind's AlphaFold to predict proteins -- has been trapped in one conspicuously narrow dimension: The AI sees things ...
LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. ...
Transformer-based models have rapidly spread from text to speech, vision, and other modalities. This has created challenges for the development of Neural Processing Units (NPUs). NPUs must now ...
More than any of the many headline achievements of artificial intelligence -- winning at chess, predicting the folding of proteins, labeling cats and dogs -- the form of AI known as generative AI has ...
During COVID-19 the switch to a virtual learning platform changed the way in which students digested content from their education. Now that the pandemic has slowed, the question of the need for online ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results